Search

everythinglearnresearchcommunity

for

Search:↓

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Bats in Puebla, Mexico, show hair loss likely due to environmental stress from human activities.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

EGFR inhibitors for lung cancer can cause severe skin issues.

Higher cholesterol levels increase aggressive prostate cancer risk.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Bald men may have a lower risk of testicular cancer.

Women with alopecia may have a higher chance of getting thyroid cancer.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Men with baldness are more prone to skin cancers on the scalp due to sun exposure, not testosterone.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Ultrasound and nanocarriers could make breast cancer treatment safer and more effective.

Physical activity, height, and smoking affect prostate cancer risk.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.